Teladoc Health, Inc. (TDOC) Operating Cash Flow CAGR:-4.23%(TTM)
Operating cash flow CAGR uses precomputed cash-flow statement history (cash from operations, before capital expenditures).
Over longer horizons, Teladoc Health, Inc.'s Operating Cash Flow CAGR averages 7.13% over 3 years and 26.36% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Operating cash flow CAGR measures the compound annual growth rate of the cash Teladoc Health, Inc. generates from its core business operations, before capital expenditures, computed from rolling-twelve-month cash-flow statement history.
TDOC Operating Cash Flow CAGR Chart
Teladoc Health, Inc. (TDOC)
TDOC Quarterly Operating Cash Flow Growth (YoY)
Operating Cash Flow growth vs the same quarter one year earlier, last 20 quarters.
TDOC Operating Cash Flow CAGR History
| Year | Start OCF | End OCF | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $293.68M | $294.36M | +$677.00K | +0.23% | +0.23% |
| 2024 | $350.02M | $293.68M | $-56.34M | -16.10% | -16.10% |
| 2023 | $189.29M | $350.02M | +$160.73M | +84.91% | +84.91% |
| 2022 | $193.99M | $189.29M | $-4.70M | -2.42% | -2.42% |
| 2021 | $-53.51M | $193.99M | +$247.50M | N/A | N/A |
| 2020 | $29.87M | $-53.51M | $-83.38M | -279.15% | N/A |
| 2019 | $-4.86M | $29.87M | +$34.73M | N/A | N/A |
| 2018 | $-34.44M | $-4.86M | +$29.58M | N/A | N/A |
| 2017 | $-51.80M | $-34.44M | +$17.35M | N/A | N/A |
| 2016 | $-47.18M | $-51.80M | $-4.61M | N/A | N/A |
| 2015 | $-11.36M | $-47.18M | $-35.82M | N/A | N/A |
| 2014 | $-6.05M | $-11.36M | $-5.31M | N/A | N/A |
Quarterly Operating Cash Flow: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $9.52M | -89.2% | -40.2% |
| Q4 2025 | $87.74M | -11.6% | +2.1% |
| Q3 2025 | $99.26M | +8.6% | -9.9% |
| Q2 2025 | $91.43M | +474.4% | +3.1% |
| Q1 2025 | $15.92M | -81.5% | +78.5% |
| Q4 2024 | $85.90M | -22.0% | -34.0% |
| Q3 2024 | $110.17M | +24.2% | +4.3% |
| Q2 2024 | $88.68M | +894.2% | -12.4% |
| Q1 2024 | $8.92M | -93.1% | -32.2% |
| Q4 2023 | $130.08M | +23.2% | +98.5% |
| Q3 2023 | $105.60M | +4.4% | +67.6% |
| Q2 2023 | $101.18M | +669.1% | +9.4% |
| Q1 2023 | $13.16M | -79.9% | — |
| Q4 2022 | $65.55M | +4.0% | -21.2% |
| Q3 2022 | $63.02M | -31.8% | -17.7% |
| Q2 2022 | $92.47M | — | +77.1% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita